{"id":18238,"date":"2024-01-16T04:30:00","date_gmt":"2024-01-16T09:30:00","guid":{"rendered":"https:\/\/dbv-technologies.com\/press_releases\/bilan-semestriel-du-contrat-de-liquidite-dbv-technologies-avec-oddo-bhf-10\/"},"modified":"2024-01-16T16:36:25","modified_gmt":"2024-01-16T21:36:25","slug":"bilan-semestriel-du-contrat-de-liquidite-dbv-technologies-avec-oddo-bhf-10","status":"publish","type":"press_releases","link":"https:\/\/dbv-technologies.com\/fr\/press_releases\/bilan-semestriel-du-contrat-de-liquidite-dbv-technologies-avec-oddo-bhf-10\/","title":{"rendered":"Bilan semestriel du contrat de liquidit\u00e9 DBV Technologies avec ODDO BHF"},"content":{"rendered":"<div class=\"pr-date-globe\">January 16, 2024 16:30 ET<\/div>\n<p align=\"right\"><strong>Informations R\u00e9glement\u00e9es<\/strong><br \/>Montrouge, France, le 16 janvier (22 h 30 CET) 2024<\/p>\n<p align=\"justify\"><strong>Bilan semestriel du contrat de liquidit\u00e9 DBV Technologies avec ODDO BHF<\/strong><\/p>\n<p align=\"justify\">DBV Technologies (Euronext : DBV \u2013 ISIN : FR0010417345 \u2013 Nasdaq : DBVT), laboratoire biopharmaceutique fran\u00e7ais, publie aujourd\u2019hui le bilan semestriel de son contrat de liquidit\u00e9 avec ODDO BHF.<\/p>\n<p align=\"justify\">Au titre du contrat de liquidit\u00e9 confi\u00e9 \u00e0 ODDO BHF, portant sur les actions de la soci\u00e9t\u00e9 DBV TECHNOLOGIES, \u00e0 la date du 31 d\u00e9cembre 2023, les moyens suivants figuraient au compte de liquidit\u00e9 : <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">222 988 titres DBV Technologies,&nbsp;<\/li>\n<li style=\"text-align:justify;\"> 150 264,71 euros. <\/li>\n<\/ul>\n<p align=\"justify\">Lors de la mise en place du contrat, \u00e0 compter du 1<sup>e<\/sup> juillet 2018, les moyens suivants figuraient au compte de liquidit\u00e9 : <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">41 159 titres DBV Technologies, <\/li>\n<li style=\"text-align:justify;\">432&nbsp;367,25 euros. <\/li>\n<\/ul>\n<p align=\"justify\">Sur la p\u00e9riode du 01\/07\/2023 au 31\/12\/2023, ont \u00e9t\u00e9 ex\u00e9cut\u00e9es&nbsp;: <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">1355 transactions \u00e0 l\u2019achat,<\/li>\n<li style=\"text-align:justify;\">998 transactions \u00e0 la vente.<\/li>\n<\/ul>\n<p align=\"justify\">Sur cette m\u00eame p\u00e9riode, les volumes \u00e9chang\u00e9s ont repr\u00e9sent\u00e9&nbsp;:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">376 978 titres et 911 734,76 euros \u00e0 l\u2019achat,<\/li>\n<li style=\"text-align:justify;\">303 962 titres et 744 017,58 euros \u00e0 la vente.<\/li>\n<\/ul>\n<p align=\"justify\"><strong>\u00c0 propos de DBV Technologies <\/strong><\/p>\n<p align=\"justify\">DBV Technologies d\u00e9veloppe Viaskin\u2122, une plateforme technologique exclusive exp\u00e9rimentale avec de larges applications potentielles en immunoth\u00e9rapie. Viaskin est bas\u00e9 sur l\u2019immunoth\u00e9rapie \u00e9picutan\u00e9e, ou EPIT\u2122, et constitue la m\u00e9thode de DBV Technologies pour d\u00e9livrer des compos\u00e9s biologiquement actifs au syst\u00e8me immunitaire \u00e0 travers la peau intacte. Avec cette nouvelle classe de produits candidats non invasifs, la Soci\u00e9t\u00e9 vise \u00e0 transformer en toute s\u00e9curit\u00e9 le traitement des patients souffrant d\u2019allergies alimentaires. Les programmes de DBV Technologies sur les allergies alimentaires comprennent des \u00e9tudes cliniques en cours sur Viaskin Peanut. Le si\u00e8ge mondial de DBV Technologies est situ\u00e9 \u00e0 Montrouge, en France, et ses op\u00e9rations nord-am\u00e9ricaines sont bas\u00e9es \u00e0 Basking Ridge, dans le New Jersey. Les actions ordinaires de la Soci\u00e9t\u00e9 sont n\u00e9goci\u00e9es sur le segment B d\u2019Euronext Paris (symbole : DBV, code ISIN : FR0010417345) et les ADS de la Soci\u00e9t\u00e9 (chacun repr\u00e9sentant une demi-action ordinaire) sont n\u00e9goci\u00e9s sur le Nasdaq Global Select Market (symbole : DBVT).<\/p>\n<\/p>\n<p id=\"gnw_attachments_section-header\">    <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=QHCDnnk-xS-XF-ufUBaNBqGoGjQHgpbNeCEOfyc1E_ZXKDopul3aAoxqEMqy7ygh79iCNEOdPxqbkcBKKXbxIonMUhqAaD9a5HRoQoqCtXVsi24GBMkbPhxKUspvbhp6usdye58zwqLT0vgf_cPo2GQBO7sSQ-l5JqztGZ1unUg=\" title=\"version PDF\" rel=\"nofollow noopener\">version PDF<\/a>      <\/li>\n<\/ul>\n<p><img decoding=\"async\" data-src=\"https:\/\/ml-eu.globenewswire.com\/media\/MTljOTBkOWItYmE3MC00Zjc3LThkM2ItZDczMTU1MjdhNmE4LTEwMTExNTI=\/tiny\/DBV-Technologies-S-A-.png\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\">            <\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"wds_primary_press_release_type":0,"footnotes":""},"press_release_type":[47],"class_list":["post-18238","press_releases","type-press_releases","status-publish","hentry","press_release_type-amf-filing"],"acf":[],"_links":{"self":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/18238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/types\/press_releases"}],"version-history":[{"count":0,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/18238\/revisions"}],"wp:attachment":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/media?parent=18238"}],"wp:term":[{"taxonomy":"press_release_type","embeddable":true,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_release_type?post=18238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}